Cigna Group (CI) Receives Buy Rating from Goldman Sachs
Goldman Sachs initiates coverage on Cigna Group with a Buy rating.
The Cigna Group is a global health company, which engages in the provision of global health services. The company is headquartered in Bloomfield, Connecticut and currently employs 73,500 full-time employees. The firm has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
Latest news, analyst ratings, earnings reports, dividends, insider trades, and market analysis for Cigna Group.
Last Updated: Dec 11, 2025, 11:06 PM · Source: Finnhub.io
Goldman Sachs initiates coverage on Cigna Group with a Buy rating.
Cigna Group (CI) has announced a quarterly dividend of $1.51 per share.
Cigna Group (CI) reported Q3 2025 EPS of $7.83 and revenue of $69.7B, meeting analyst estimates.